This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Healy, D. P. Articles by Clendening, C. E. Search for Related Content PubMed PubMed Citation Articles by Healy, D. P. Articles by Clendening, C. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 01 1996, 6-10, Vol 40, No. 1
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes

DP Healy, MC Brodbeck and CE Clendening
College of Pharmacy, University of Cincinnati, Ohio 45267, USA. Dan.Healy@UC.EDU

Twenty-six hospitalized patients participated in a randomized crossover study to evaluate the effect of enteral feedings on ciprofloxacin absorption when given orally or via gastrostomy or jejunostomy tubes. Patients in the oral group received an intact 500-mg ciprofloxacin tablet alone or ciprofloxacin plus three oral doses of Sustacal (240 ml given 8 h before, with, and 4 h after ciprofloxacin administration). Patients with gastrostomy or jejunostomy tubes received 500 mg of crushed ciprofloxacin in 60 ml water via the feeding tube. After a washout period, the patients received ciprofloxacin with a continuous enteral formula (Jevity) given at 60 to 90 ml/h beginning 6 h before drug administration and continuing for 10 h. Serial blood samples were analyzed for ciprofloxacin concentration by high-performance liquid chromatography. The maximum ciprofloxacin concentrations in serum for ciprofloxacin given and for ciprofloxacin plus enteral feeding for the oral, gastrostomy, and jejunostomy groups were (mean +/- standard deviation) 2.59 +/- 1.24 versus 1.43 +/- 0.61 micrograms/ml (P < 0.05), 3.68 +/- 1.36 versus 2.27 +/- 0.67 micrograms/ml (P < 0.05), and 3.78 +/- 1.87 versus 1.45 +/- 0.48 micrograms/ml (P < 0.05), respectively. Corresponding values for area under the concentration-time curve were 13.4 +/- 8.32 versus 9.44 +/- 4.74 micrograms/h/ml (P < 0.05) 15.9 +/- 6.62 versus 7.44 +/- 3.16 (micrograms/h/ml (P < 0.05), and 18.1 +/- 9.37 versus 5.82 +/- 2.63 micrograms.h/ml (P < 0.05). We conclude that enteral feedings given orally or via gastrostomy or jejunostomy tubes resulted in a 27 to 67% reduction in the mean bioavailability of ciprofloxacin in hospitalized patients. The decreased absorption may be clinically important, especially when the enteral feeding is coadministered with ciprofloxacin by the oral and jejunostomy tube routes. Reductions in maximum levels of ciprofloxacin in serum as a result of feedings given via a gastrostomy tube are similar to those following oral administration on an empty stomach, making a clinically important interaction by this route less likely.

This article has been cited by other articles:

• Wohlt, P. D., Zheng, L., Gunderson, S., Balzar, S. A., Johnson, B. D., Fish, J. T. (2009). Recommendations for the use of medications with continuous enteral nutrition. Am J Health Syst Pharm 66: 1458-1467 [Abstract] [Full Text]  
• Williams, N. T. (2008). Medication administration through enteral feeding tubes. Am J Health Syst Pharm 65: 2347-2357 [Abstract] [Full Text]  
• Magnuson, B. L., Clifford, T. M., Hoskins, L. A., Bernard, A. C. (2005). Enteral Nutrition and Drug Administration, Interactions, and Complications. Nutr Clin Pract 20: 618-624 [Abstract] [Full Text]  
• Beringer, P., Nguyen, M., Hoem, N., Louie, S., Gill, M., Gurevitch, M., Wong-Beringer, A. (2005). Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings. Antimicrob. Agents Chemother. 49: 3676-3681 [Abstract] [Full Text]  
• Martinez, V., Guillou, J.-L. L., Lamer, C., Jouan, M. L., Tod, M., Dromer, F. (2003). Serum Voriconazole Levels following Administration via Percutaneous Jejunostomy Tube. Antimicrob. Agents Chemother. 47: 3375-3375 [Full Text]  
• Graffunder, E. M., Venezia, R. A. (2002). Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49: 999-1005 [Abstract] [Full Text]  
• Wright, D. H., Pietz, S. L., Konstantinides, F. N., Rotschafer, J. C. (2000). Decreased In Vitro Fluoroquinolone Concentrations After Admixture With an Enteral Feeding Formulation. JPEN J Parenter Enteral Nutr 24: 42-48 [Abstract]  
• Nyffeler, M. S. (1999). Ciprofloxacin Use in the Enterally Fed Patient. Nutr Clin Pract 14: 73-77